top of page

Corona Virus - SARS

The Bill and Melinda Gates Foundation co-hosted a pandemic exercise in late 2019 that simulated a global coronavirus outbreak.

They also just happen to fund the group who owns the patent to the deadly virus and are working on a vaccine to solve the crisis.

On June 19, 2015, the UK government-funded Pirbright Institute filed an application for a patent for the live coronavirus, which was approved on Nov 20, 2018.


In this report we take an inside look at Event 201, which took place in NYC on October 18 2019. Event 201 is a high-level pandemic exercise hosted by the Johns Hopkins Center for Health Security in partnership with the World Economic Forum and the Bill and Melinda Gates Foundation.

This is extremely fascinating because this pandemic simulation exercise of coronavirus took place about 6 weeks before the first illness from the coronavirus was actually reported in wuhan china! That is one hell of a coincidence if you believe in that sort of thing. Another fascinating connection, is the fact that not only did the Bill and Melinda Gates Foundation participate in and help set up the pandemic simulation of a coronavirus outbreak, but they just so happen to fund the group who owns the patent to the deadly coronavirus and are already working on a vaccine to solve the current crisis. Again an incredible coincidence…

In this report you will see footage from inside the event as the members of the emergency epidemic board in this simulation, which consists of representatives from major banks, the UN, the Bill and Melinda Gates Foundation, Johnson and Johnson, logistical powerhouses, the media as well as officials from China and America’s CDC just to name a few. This simulation also includes news reports that were fabricated just for this exercise, please keep that in mind because they are eerily similar to reports we are currently seeing regarding this real world coronavirus outbreak.

QAnon Supporters And Anti-Vaxxers Are Spreading A Hoax That Bill Gates Created The Coronavirus

Freeemasonry Highest Order 33.

Gates test Run.

The exact origin of the virus is unknown at this time – although it is thought to have emerged at a seafood market in Wuhan, China.

It is also thought that the first people infected with the new coronavirus contracted it from animals, because coronaviruses are known to move from animals to humans.

A report by the Wuhan Institute for Virology found that the new coronavirus’ genetic makeup was 96 per cent identical to the kind found in bats, which were also the original source of SARS.

In light of this information, videos which appear to show Chinese people eating bats have circulated over the past few weeks, with some people blaming Chinese eating habits for the outbreak.

-------- Original Message -------- Subject: Coronavirus: Now That It's A National Emergency, Is It 'Too Late'? The chap that sent this is a serious scientist M Looks like we are in for an economic and social collapse. Paul Please take a look at this information as it may very important for your future survival!! You need to understand what is going on with this corona virus pandemic. This virus is a genetically modified lab made fast attack nasty deadly Bio-weapon created from these components.

The bat SARS virus, NIPA virus (75% death rate) with HIV modifications to AC4 binding attack proteins to bypass your immune system. There are other components in the virus genome that have not yet been identified by researchers using genome databases that are available to them.

I am currently investigating if any of these other unidentified edited virus structure or other components may have some relationship to the 5G cellular systems the were activated in WUAN 1 week prior to the virus outbreak. There could be a radio frequency kill switch in this virus in genome code structures.

The never release a bioweapon with out a kill switch rule applies here. This virus mutates 7 to 14 times in each person infected by it’s design to so a vaccine for it is very unlikely and you can get it more than one time. It is here right now and it has a r0 value that is estimated to be 4.03 to 5.00. This means that only a nearly full shutdown of all human interactions in the USA ( as is being done in China right now because they know this fact ) can slow virus this down. The data shows that males appear to have a 66% percent greater chance of serious ICU type complications for the virus due to more AC4 receptor suites in the male lung tissue. 20% to 25% if the infections result in a serious complication requiring ICU types of treatment. More the 50% of the severe cases result in mortality and the death rate increases if you over 50 years old. You need to understand what this means to you and your family so can prepare for this in your specific location and situation.

You need to find out what you are not being told by the mainstream media. I pray that YAWH watch over all of us. Hans Becker Here is the best information that I have right now to share with all of you please take a look at this. Coronavirus: Now That It's A National Emergency, Is It 'Too Late'? Coronavirus and HIV research paper review by Dr. Paul Cottrell Here are the two tube channels you need check it every day for updates on this situation. Dr. Paul Cottrell This information is pure gold on understanding what you need to do in this situation to help you and your family survive this outbreak. Dr. Chris Martenson Phd Peak Prosperity This is the HIV drug they are testing to stop the effect of the Bioweapons HIV additions from stopping the immune system from fighting the virus in the lung2 AC4 receptor site. Johnson & Johnson’s multi-pronged approach also includes a review of known pathways in coronavirus pathophysiology to determine whether previously tested medicines can be used to help patients survive a 2019-nCoV infection and reduce the severity of disease in non-lethal cases. In addition, Janssen has donated 300 boxes of its HIV medication PREZCOBIX® (darunavir/cobicistat) to the Shanghai Public Health Clinical Center and Zhongnan Hospital of Wuhan University for use in research to support efforts in finding a solution against the 2019-nCoV. Furthermore, another 50 boxes have been provided to the Chinese Center for Disease Control and Prevention for laboratory-based investigations (drug-screening for antiviral properties against 2019-nCoV). All shipments have been delivered and, if further donations are required, the Company is open to cooperating with all healthcare institutions and agencies to support efforts in finding a solution against 2019-nCoV. The requests from the Shanghai Public Health Clinical Center and Zhongnan Hospital of Wuhan University follow a recommendation from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences for investigation of 30 potentially effective compounds, including darunavir – the protease inhibitor component of PREZCOBIX – against 2019-nCoV. Based on anecdotal findings, a protease inhibitor has previously shown a potential favorable clinical response against severe acute respiratory syndrome (SARS) associated coronavirus.[i]

The Company’s expedited research and development schedule is in response to the current 2019-nCoV

I am researching other agents would help you if you are exposed to the virus. I looks like getting a supply of this will help the immune system respond to the virus infection before the HIV components kick in turn off the immune response.

ELDERBERRY SYRUP Item #: HYG1006 / 2162402 Write a review Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. Zakay-Rones Z1, Thom E, Wollan T, Wadstein J. Author information

Abstract Elderberry has been used in folk medicine for centuries to treat influenza, colds and sinusitis, and has been reported to have antiviral activity against influenza and herpes simplex. We investigated the efficacy and safety of oral elderberry syrup for treating influenza A and B infections. Sixty patients (aged 18-54 years) suffering from influenza-like symptoms for 48 h or less were enrolled in this randomized, double-blind, placebo-controlled study during the influenza season of 1999-2000 in Norway. Patients received 15 ml of elderberry or placebo syrup four times a day for 5 days, and recorded their symptoms using a visual analogue scale. Symptoms were relieved on average 4 days earlier and use of rescue medication was significantly less in those receiving elderberry extract compared with placebo. Elderberry extract seems to offer an efficient, safe and cost-effective treatment for influenza. These findings need to be confirmed in a larger study. PMID: 15080016 DOI: 10.1177/147323000403200205

Featured Posts
Recent Posts
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square
bottom of page